Heidelberg biochemists and structural biologists from Shanghai unravel the roles of two key regulatory factors in mRNA ...

Scientists say they have found a pattern of so-called epigenetic 'marks' in a transition state between normal and pancreatic cancer cells in mice, and that the normal cells may keep at least a ...

Scientists found that pseudouridine helps small RNAs pass on traits and avoid immune detection, offering clues for future RNA ...

Single-Molecule Footprinting reveals that RNA polymerase II (Pol II) occupancy is infrequent at mouse promoters. This results ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

In parallel, scientists had been working with mRNA vaccines for cancer and infectious disease ... Within just three months of receiving the genetic sequence of the virus in January 2020, Oxford ...

To investigate protein–protein interactions, an ideal protein-selection method should allow the identification of the target-interacting sequences from both natural protein and synthetic peptide ...

Only recently has the ribosome - one of the oldest molecular machines in evolutionary terms - been recognized as an active regulator of gene expression at the level of protein biosynthesis.

AI-generated image of cancer being attacked by an mRNA vaccine. In the midst of the COVID-19 pandemic, scientists raced to develop vaccines in record time. The first reliable vaccines, using ...

The mRNA Vaccines Market grew from USD 9.32 billion in 2024 to USD 10.40 billion in 2025. It is expected to continue growing at a CAGR of 11.86%, reaching USD 18.28 billion by 2030.

National Institutes of Health officials have urged scientists to remove all references to mRNA vaccine technology from their grant applications, two researchers said, in a move that signaled the ...